Hydrogels derived from decellularized liver tissue support the growth and differentiation of cholangiocyte organoids

Jorke Willemse,Gilles van Tienderen,Eline van Hengel,Ivo Schurink,Diana van der Ven,Yik Kan,Petra de Ruiter,Oskar Rosmark,Gunilla Westergren-Thorsson G,Kerstin Schneeberger,Bram van der Eerden,Henk Roest,Bart Spee,Luc van der Laan,Jeroen de Jonge,Monique Verstegen
DOI: https://doi.org/10.1016/j.biomaterials.2022.121473
IF: 14
Biomaterials
Abstract:Human cholangiocyte organoids are promising for regenerative medicine applications, such as repair of damaged bile ducts. However, organoids are typically cultured in mouse tumor-derived basement membrane extracts (BME), which is poorly defined, highly variable and limits the direct clinical applications of organoids in patients. Extracellular matrix (ECM)-derived hydrogels prepared from decellularized human or porcine livers are attractive alternative culture substrates. Here, the culture and expansion of human cholangiocyte organoids in liver ECM(LECM)-derived hydrogels is described. These hydrogels support proliferation of cholangiocyte organoids and maintain the cholangiocyte-like phenotype. The use of LECM hydrogels does not significantly alter the expression of selected genes or proteins, such as the cholangiocyte marker cytokeratin-7, and no species-specific effect is found between human or porcine LECM hydrogels. Proliferation rates of organoids cultured in LECM hydrogels are lower, but the differentiation capacity of the cholangiocyte organoids towards hepatocyte-like cells is not altered by the presence of tissue-specific ECM components. Moreover, human LECM extracts support the expansion of ICO in a dynamic culture set up without the need for laborious static culture of organoids in hydrogel domes. Liver ECM hydrogels can successfully replace tumor-derived BME and can potentially unlock the full clinical potential of human cholangiocyte organoids.
What problem does this paper attempt to address?